Federal Register / Vol. 71, No.
97 / Friday, May 19, 2006 / Notices 29163
Virginia, Court of Federal Claims
Number 06–0145V
48. Sandra and Justin Meyer on behalf
of Justin Meyer, Port Arthur, Texas,
Court of Federal Claims Number
06–0148V
49. Holly and Joshua Winstead on
behalf of Jeremy Winstead, Athens,
Georgia, Court of Federal Claims
Number 06–0159V
50. Randi and Michael Bryant on behalf
of Kyle Bryant, Baldwinsville, New
York, Court of Federal Claims
Number 06–0162V
51. Tracie and Brad Childress on behalf
of Nathan Childress, Sparkill, New
York, Court of Federal Claims
Number 06–0163V
52. Linda and Daniel Moffitt on behalf
of Robert Moffitt, Orangeburg, New
York, Court of Federal Claims
Number 06–0164V
53. Svitlana Budzak-Jones and Laird
Jones on behalf of William
Oleksandr Jones, State College,
Pennsylvania, Court of Federal
Claims Number 06–0165V
54. Suanne and Bradley Knutson on
behalf of Jack Bradley Knutson,
Sioux Falls, South Dakota, Court of
Federal Claims Number 06–0166V
55. Debra Ann Anderson, Sioux Falls,
South Dakota, Court of Federal
Claims Number 06–0168V
56. Anita Reino on behalf of Angela
Reino, Thonotosassa, Florida, Court
of Federal Claims Number 06–
0170V
57. Meghan Bramlage on behalf of
Mitchell Bramlage, Boston,
Massachusetts, Court of Federal
Claims Number 06–0171V
58. Jolee Carney on behalf of Jordan
Custer, Deceased, Ellsworth,
Washington, Court of Federal
Claims Number 06–0187V
59. Sarah and Christopher Hoiberg on
behalf of Caitlyn Joy Hoiberg,
Jacksonville, Florida, Court of
Federal Claims Number 06–0188V
60. Tamar Feld, Englewood, New Jersey,
Court of Federal Claims Number
06–0190V
61. Louis Tosches, II on behalf of Louis
Tosches, III, Towson, Maryland,
Court of Federal Claims Number
06–0192V
62. Jessica Kuttner on behalf of Calvin
Kuttner, Traverse City, Michigan,
Court of Federal Claims Number
06–0195V
63. Stephanie Coleman on behalf of
Lincoln Coleman, Boston,
Massachusetts, Court of Federal
Claims Number 06–0197V
wwhite on PROD1PC61 with NOTICES
64. James Robert Dickman on behalf of
Lindsay Kathleen Dickman,
Deceased, New York, New York,
Court of Federal Claims Number
06–0199V
VerDate Aug<31>2005 17:37 May 18, 2006 Jkt 208001
65. Roberta and Ronald Moore on behalf
of Daniel Moore, Tampa, Florida,
Court of Federal Claims Number
06–0200V
66. Patricia and Vincent Miller on
behalf of John Miller, West Orange,
New Jersey, Court of Federal Claims
Number 06–0201V
67. Linda and Charles Veneman on
behalf of Linda Veneman,
Henderson, Nevada, Court of
Federal Claims Number 06–0203V
68. Linda and Charles Veneman on
behalf of Linda Veneman,
Henderson, Nevada, Court of
Federal Claims Number 06–0204V
69. Naomi and Emanuel Goldman on
behalf of Tamara June Goldman,
Deceased, West Orange, New Jersey,
Court of Federal Claims Number
06–0206V
70. Bethany and Randall Loudenslager
on behalf of Zachary Loudenslager,
Strongsville, Ohio, Court of Federal
Claims Number 06–0207V
71. Lee and William Hinton on behalf of
William S. Hinton, Jr., Mountain
Brook, Alabama, Court of Federal
Claims Number 06–0208V
72. Lynn and Shawn Sevey on behalf of
Shalyn Sevey, Folsom, California,
Court of Federal Claims Number
06–0209V
73. Tamara Charles on behalf of Jeron
Charles, Brooklyn, New York, Court
of Federal Claims Number 06–
0212V
74. Jaynna and Eric Moxley on behalf of
Mary Madison Moxley, Cabot,
Arkansas, Court of Federal Claims
Number 06–0213V
75. Carina Dewitt-Lord and Richard
Lord on behalf of Zachary Dylan
Lord, Philadelphia, Pennsylvania,
Court of Federal Claims Number
06–0215V
76. Lynne Paumier, Downington,
Pennsylvania, Court of Federal
Claims Number 06–0220V
77. Hilmi and Samar Amar on behalf of
Rushia Amar, Arlington, Texas,
Court of Federal Claims Number
06–0221V
78. Parivash and Saeid Mojabi on behalf
of Ryan Mojabi, San Jose,
California, Court of Federal Claims
Number 06–0227V
79. Penny and Richard Majewski on
behalf of Zachary Adam Majewski,
Somers Point, New Jersey, Court of
Federal Claims Number 06–0229V
80. Diane and Samuel Yellis on behalf
of Sophie Yellis, Lake Success, New
York, Court of Federal Claims
Number 06–0234V
81. Gayle Delong and Jonathan Rose on
behalf of Flora Rose, Morristown,
New Jersey, Court of Federal Claims
Number 06–0235V
PO 00000 Frm 00045 Fmt 4703 Sfmt 4703
82. Lori and Kevin Champagne on
behalf of Jared Champagne,
Baldwinsville, New York, Court of
Federal Claims Number 06–0248V
83. Adrian Green and Nathaniel
Armstrong, Jr. on behalf of Nijieh
Green, Philadelphia, Pennsylvania,
Court of Federal Claims Number
06–0249V
84. Geetha Srinivasarao and
Cholanayakanahalli Vinayak on
behalf of Praveen Vinayak,
Washington, D.C., Court of Federal
Claims Number 06–0250V
85. Denise and James Walker on behalf
of Nicholas John Walker, East
Stroudsburg, Pennsylvania, Court of
Federal Claims Number 06–0252V
86. Rena DeFelice on behalf of Carson
DeFelice, Katy, Texas, Court of
Federal Claims Number 06–0253V
87. Heather and Adrian Aschmann on
behalf of Adrian Aschmann, Estell
Manor, New Jersey, Court of Federal
Claims Number 06–0256V
88. Daphne and John Dunstan on behalf
of William Dunstan, Philadelphia,
Pennsylvania, Court of Federal
Claims Number 06–0257V
Dated: May 15, 2006.
Elizabeth M. Duke,
Administrator.
[FR Doc. E6–7665 Filed 5–18–06; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review;
Comment Request; a Process/
Outcome Evaluation of Parkinson’s
Disease Research Centers
SUMMARY: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institute of Neurological Disorders and
Stroke (NINDS) Office of Science Policy
and Planning, the National Institute of
Health (NIH) has submitted to the Office
of Management and Budget (OMB) a
request for review and approval of the
information collection listed below.
This proposed information collection
was previously published in the Federal
Register on December 21, 2005, pages
75823–75824, and allowed 60-days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. The National
Institutes of Health may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
E:\FR\FM\19MYN1.SGM 19MYN1
 29164 Federal Register / Vol. 71, No. 97 / Friday, May 19, 2006 / Notices

October 1, 1995, unless it displays a conducted by the Udall Centers, the Udall Centers Program. Lastly, Udall
currently valid OMB control number. relationship between Center activities Center awardees will be able to use the
Proposed Collection: Title: A Process/ and the achievement of program goals, evaluation results to improve the
Outcome Evaluation of Parkinson’s and the NINDS management of the performance of their Centers; and other
Disease Research Centers Type of program. The results of the full-scale NIH Institutes and Centers may use the
Information Collection Request: NEW. evaluation should be very helpful to methodology and results of this
Need and Use of Information Collection: NINDS in identifying the most relevant evaluation to guide their own centers
This study is primarily an outcome measures for tracking the future assessments. Frequency of Response:
evaluation, designed to assess the extent progress of the Centers, developing Once or twice. Affected Public:
to which the NINDS-funded Morris K. strategies to enhance the program’s Researchers, Not-for-profit institutions;
Udall Centers for Excellence in effectiveness, and improving program
Federal Government; individuals or
Parkinson’s Disease Research have management. NINDS will also use the
households. Type of Respondents: Adult
achieved the program’s short-term and findings to inform its National Advisory
long-term goals. The study also includes Neurological Disorders and Stroke professionals.
elements of a process evaluation in its Council, and to address inquiries from The annual reporting burden is
examination of the major activities the public regarding the impact of the provided in the following table:

Estimated Estimated Estimated Estimated

Type of respondents number of frequency of average time annual hour
respondents response per response burden

Center Directors ............................................................................................... 13 2 1.5 39

Project/Core Directors ..................................................................................... 54 2 1.5 162
Comparison Group .......................................................................................... 54 1 1.0 54

Totals ........................................................................................................ 121 ........................ ........................ 255

There are no Capital Costs to report. and Planning, National Institute of for companies and may also be available
There are no Operating or Maintenance Neurological Disorders and Stroke, NIH, for licensing.
Costs to report. Building 31, 31 Center Drive, Room 8A– ADDRESSES: Licensing information and
Request for Comments: Written 03, Bethesda, MD 20892; call non-toll- copies of the U.S. patent applications
comments and/or suggestions from the free 301–496–9271; or E-mail your listed below may be obtained by writing
public and affected agencies should request, including your address to: to the indicated licensing contact at the
address one or more of the following ospp@ninds.nih.gov. Office of Technology Transfer, National
points: (1) Evaluate whether the Comments Due Date: Comments Institutes of Health, 6011 Executive
proposed collection of information is regarding this information collection are Boulevard, Suite 325, Rockville,
necessary for the proper performance of best assured of having their full effect if Maryland 20852–3804; telephone: (301)
the function of the agency, including received within 30-days of the date of 496–7057; fax: (301) 402–0220. A signed
whether the information will have this publication. Confidential Disclosure Agreement will
practical utility; (2) Evaluate the Dated: May 11, 2006. be required to receive copies of the
accuracy of the agency’s estimate of the Story C. Landis, patent applications.
burden of the proposed collection of Director, NINDS, National Institutes of
information, including the validity of Viral Entry or Replication Inhibition
Health. Using siRNA, Small Molecules, or
the methodology and assumptions used; [FR Doc. E6–7626 Filed 5–18–06; 8:45 am]
(3) Enhance the quality, utility, and Other Tec Tyrosine Kinase Inhibitors
BILLING CODE 4140–01–P
clarity of the information to be Julie Readinger and Pamela L.
collected; and (4) Minimize the burden Schwartzberg (NHGRI).
of the collection of information on those DEPARTMENT OF HEALTH AND U.S. Provisional Application filed 29
who are to respond, including the use HUMAN SERVICES Mar 2006 (HHS Reference No. E–151–
of appropriated automated, electronic, 2006/0–US–01).
mechanical, or other technological National Institutes of Health Licensing Contact: Susan Ano; 301/435–
collection techniques or other forms of 5515; anos@mail.nih.gov.
information technology. Government-Owned Inventions; The Tec family of tyrosine kinases,
FOR FURTHER INFORMATION CONTACT: Availability for Licensing consisting of five family members Tec,
Written comments and/or suggestions AGENCY: National Institutes of Health, Btk, Itk, Rlk, and BMX, are key
regarding the item(s) contained in this Public Health Service, HHS. regulators of signaling pathways of T
notice, especially regarding the ACTION: Notice. lymphocytes. Many existing antiviral
estimated public burdenand associated therapies rely on inhibition of viral
response time, should be directed to the: SUMMARY: The inventions listed below replication, which leads to emergence or
Office of Management and Budget, are owned by an agency of the U.S. selection of resistant viruses. The
Office of Regulatory Affairs, New Government and are available for current technology provides an
Executive Office Building, Room 10235, licensing in the U.S. in accordance with alternative target for the prevention or
Washington, DC 20503, Attention: Desk 35 U.S.C. 207 to achieve expeditious treatment of viral infection through
wwhite on PROD1PC61 with NOTICES

Officer for NIH. To request more commercialization of results of administration of a Tec tyrosine kinase
information on the proposed project or federally-funded research and inhibitor. Such inhibitors can be siRNA,
to obtain a copy of the data collection development. Foreign patent small chemical compounds, antisense or
plans and instruments, contact: Dr. applications are filed on selected antibody. The current technology
Melinda Kelley, Office of Science Policy inventions to extend market coverage describes the inhibition of Itk (also

VerDate Aug<31>2005 17:37 May 18, 2006 Jkt 208001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\19MYN1.SGM 19MYN1